AR

Anticancer Research

Anticancer Research is a cancer journal published by the International Institute of Anticancer Research. The journal website features current issues, featured articles, latest articles, special issues, and article-level purchase options, with some articles marked as open access.

Looking to publish in Anticancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 1.7
Quartile Q4
Open Access Type Closed
ISSN 0250-7005
eISSN 1791-7530
Invitation Only No
Cost Range Individual articles can be purchased for $30.

Submission Instructions

Anticancer Research accepts the following article types. Click on an article type to view submission instructions.

Full Papers

Cover Letter A submission letter signed by all authors confirming approval of the article contents is required. The submission letter must confirm that all authors approve the article contents.
Abstract An abstract is required. Abstract must not exceed 280 words. Abstract must be structured. Abstract headings must be Background/Aim, Materials and Methods/Patients and Methods, Results, and Conclusion.
Manuscript Full Papers of more than 5 printed pages, approximately 12 double-spaced document pages at about 250 words per page including abstract, text, tables, figures, and references, incur excess page charges. Manuscript must be divided into Introduction, Materials and Methods/Patients and Methods/Case Report, Results, Discussion, Conclusion, Conflicts of Interest, Authors’ Contributions, Acknowledgements, Funding, AI Disclosure, and References. The first page must include key words, and the manuscript must include Conflicts of Interest, Authors’ Contributions, Funding, and AI Disclosure sections with disclosure of any artificial intelligence tool use and its extent and purpose.
References References must be numbered consecutively and cited in the text by number in parenthesis.
Figures & Tables All figures and tables must appear at the end of the submitted document file. Figures must be numbered with Arabic numerals and tables with Latin numerals according to their sequence in the text.
Reformat to Anticancer Research using Livewrite Premium

Review Articles

Cover Letter A submission letter signed by all authors confirming approval of the article contents is required. The submission letter must confirm that all authors approve the article contents.
Abstract An abstract is required. Abstract must not exceed 280 words. Abstract must be structured. Abstract headings must be Background/Aim, Materials and Methods/Patients and Methods, Results, and Conclusion.
Manuscript Review Articles must not exceed 35 pages at approximately 250 words per double-spaced typed page, including all tables, figures, and references. Review Articles may follow a different style according to the subject matter and the author’s opinion. The first page must include key words, and the manuscript must include sections for Conflicts of Interest, Authors’ Contributions, Funding, AI Disclosure, Acknowledgements, and References.
References References must be numbered consecutively and cited in the text by number in parenthesis.
Figures & Tables All figures and tables must appear at the end of the submitted document file. Figures must be numbered with Arabic numerals and tables must be numbered according to their sequence in the text.
Reformat to Anticancer Research using Livewrite Premium

Letters To The Editor

Cover Letter A submission letter signed by all authors is required. The submission letter must confirm all authors’ approval of the article contents.
Abstract Abstract requirements are not specified.
Manuscript Key words, conflicts of interest, authors’ contributions, funding, acknowledgements, and an AI disclosure must be included.
References References must be numbered consecutively and cited in the text by number in parenthesis.
Figures & Tables All figures and tables must appear at the end of the submitted document file.
Reformat to Anticancer Research using Livewrite Premium

Case Reports

Cover Letter A submission letter signed by all authors is required. The submission letter must confirm approval of the article contents by all authors.
Abstract An abstract is required. Abstract must not exceed 280 words. Abstract must be structured. Abstract must use the headings Background/Aim, Case Report, and Conclusion.
Manuscript Manuscript must be divided into the sections Introduction, Case Report, Discussion, Conclusion, Conflicts of Interest, Authors’ Contributions, Acknowledgements, Funding, AI Disclosure, and References. The first page must include key words, and the manuscript must include Conflicts of Interest, Authors’ Contributions, Funding, and AI Disclosure sections with disclosure of any artificial intelligence tool use and its extent and purpose.
References References must be numbered consecutively and cited in the text by number in parenthesis.
Figures & Tables All figures and tables must appear at the end of the submitted document file. Figures must be numbered with Arabic numerals and tables must be numbered according to their sequence in the text.
Reformat to Anticancer Research using Livewrite Premium

Recent Publications

Expression of Concern

-

10.21873/anticanres.18276
View Publication

The Prognostic Impact of Perioperative Inflammatory Status in Elderly Patients With Gastric Cancer

TAKAHIRO TOYOKAWA, MAMI YOSHII, TAKEMI ISHIDATE, HIRONARI MIYAMOTO, KENJI KURODA, YUICHIRO MIKI, TATSURO TAMURA, SHIGERU LEE, MASAKAZU YASHIRO, KIYOSHI MAEDA

10.21873/anticanres.18199
View Publication

Pretreatment Tumor Growth Rate and Clinical Outcomes in Advanced Non–small Cell Lung Cancer

YUTAKA TAKAHARA, RYUDAI ABE, SUMITO NAGAE, TAKUYA TANAKA, YOKO ISHIGE, IKUYO SHIONOYA, KOUICHI YAMAMURA, MASAFUMI NOJIRI, MASAHARU IGUCHI

10.21873/anticanres.18208
View Publication

Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer

YUTA MURAI, KIICHI SUGIMOTO, TAKAHIRO IRIE, TAKASHI FUJISAKI, ATSUHIKO HAMADA, YUJI ANDO, SAKI KOCHI, MIYUKI TOAKE, YUKI NAKAGAWA, HIROMITSU TAKAHASHI, HIROTAKA MOMOSE, YUKI TSUCHIYA, RYOICHI TSUKAMOTO, HISASHI RO, KUMPEI HONJO, MAKOTO TAKAHASHI, ROBERT M. HOFFMAN

10.21873/anticanres.18196
View Publication

Clinical Outcomes and Prognostic Factors in Patients With Pelvic Sarcomas

MASANORI KAWANO, YUTA KUBOTA, ICHIRO ITONAGA, NOBUHIRO KAKU, KAZUHIRO TANAKA

10.21873/anticanres.18215
View Publication

Frequently asked questions

How long does it take to publish?

Prompt publication generally within 1-2 months from final acceptance. Acknowledgment of receipt is sent upon receipt, with follow-up advised if not received within 20 days from submission. Reviewers are asked to return comments within 12 days from receipt. Corrected galley proofs should be returned within 24 hours.

Reformat to Anticancer Research using Livewrite Premium

Is a cover letter required?

A signed submission letter confirming approval of the article contents by all authors is required.

Reformat to Anticancer Research using Livewrite Premium

What are the publication costs?

Individual articles can be purchased for $30.

Reformat to Anticancer Research using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Esophageal Cancer Research and Treatment Hepatocellular Carcinoma Treatment and Prognosis Gastric Cancer Management and Outcomes Cancer Cells and Metastasis Inflammatory Biomarkers in Disease Prognosis Head and Neck Cancer Studies Pancreatic and Hepatic Oncology Research Colorectal Cancer Surgical Treatments Breast Cancer Treatment Studies Cholangiocarcinoma and Gallbladder Cancer Studies Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer, Stress, Anesthesia, and Immune Response Colorectal Cancer Treatments and Studies Cancer Research and Treatments Prostate Cancer Treatment and Research Lung Cancer Diagnosis and Treatment Cancer, Hypoxia, and Metabolism Prostate Cancer Diagnosis and Treatment Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Renal cell carcinoma treatment Immunotherapy and Immune Responses Bladder and Urothelial Cancer Treatments

Related Journals

SC
Stem Cells Oxford University Press
TA
Therapeutic Advances in Medical Oncology SAGE Publishing
JF
Journal for ImmunoTherapy of Cancer BMJ
JP
JCO Precision Oncology LIPPINCOTT WILLIAMS & WILKINS
BR
Biomarker Research BioMed Central
CG
Cancer Gene Therapy Springer Nature